ISSN 2321–3647
Sun, 19 Nov 2017

Role of HPT Markers in β Thalassemia Major Patients

Surbhi Choubey*1 , Anupama Patne1

1.Peoples college of medical science and research centre, Bhopal(M.P.)


Patients of beta thalassemia major undergo frequent blood transfusion along with chelating therapy as a part of their treatment regimen which considerably prolonged survival of patients. However, hyper-perfusion results in iron deposition in multiple endocrine glands which leads to endocrine dysfunction. Hypoparathyrodism is a well known syndrome which is associated with beta thalassemia and seems to be cause of hypocalcemia and hyperphosphatemia. The cause of hypoparathyrodism is assumed to be due to iron deposition in parathyroid glands. This study is conducted to determine the serum calcium and phosphorous in 30 patients of beta thalassemia major. We recommend parathyroid hormone profile should be checked regularly in all patients with transfusion dependent beta thalassemia major and suggest that these tools may be applicable to other cases of suspected HPT.

Keywords: Beta thalassemia, Hypoparathyrodism, Calcium, Phosphorous


[PDF]  Viewed: 379  Downloaded: 75
  • Call for paper
    Call for paper

    American Journal of Pharmacy and Health Research (AJPHR) is a peer-reviewed, monthly official international journal allowing access to abstracts and full-text.

  • Email & SMS Alerts
    Email & SMS Alerts

    Email/SMS alert system is one of the key features and gives update information about the submitted manuscript.


  • Article Statastics
    Article Statastics

    American Journal of Pharmacy and Health Research (AJPHR) provides unique facility for authors to know popularity of articles on basis of numbers of PDF download and views. It will display in tabulated format.

  • Online Submission
    Online Submission

    American Journal of Pharmacy and Health Research (AJPHR) is one of the International open access journal devoted to various disciplines in science and technology.


web counter
web counter